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Background & Aims: The l i v e r ,   being the   major site   of i r o n  storage, is particularly 
exposed to the toxic effects of iron.  Tran- scription factor NRF2 is critical for protecting 
the l i v e r  a g a i n s t  disease by activating the transcription of genes encoding detoxi- 
fication/antioxidant enzymes. We aimed to determine if the NRF2 pathway plays a 
significant role in the protection against hepatic iron overload. 
Methods: Wild type and   Nrf2_ /_   mouse primary hepatocytes 
Wereincubated with ferric   ammonium citrate. Wild type and Nrf2-/- mice w e r e fed 
standa rd  rodent chow or iron-rich diet for 2 weeks, with or without daily in je ct io n  of 
the a n t i o x i d a n t  mito-TEMPOL. 
Results: In mouse hepatocytes, iron induced the nuclear translo- cation of NRF2 and the 
expression of cytoprotective genes in an NRF2-dependent manner.  Moreover, Nrf2 _ /_     
hepatocytes were highly susceptible to i r o n -induced cell d e a t h . Wild-type and 
Nrf2 _ /_ mice  fed  iron-rich diet  accumulated similar amounts of iron  in the  liver  and  
were equally able  to increase the  expression of hepatic hepcidin and  ferritin. 
Nevertheless, in Nrf2-null mice the iron loading resulted in progressive liver injury, 
ranging from mild   confluent necrosis to s e v e r e  necroinflammatory lesions. 
Hepatocytic cell death was associated with gross ul tra st ru c tu ra l  damage to the 
mitochondria. Notably, liver injury was prevented in iron-fed animals that received mito-
TEMPOL. 
Conclusions: NRF2 protects the mo u se  liver against the toxi c i ty  of dietary iron 
o v e r l o a d  by p r e v e n t i n g  hepatocytic cell d e a t h . We identify NRF2 as a potential 
modifier of liver disease in iron overload pathology and show the beneficial effect of 
the antiox- idant mito-TEMPOL in a mouse model of dietary iron-induced liver injury. 
  ©2013 European Association for the Study of the Liver. Published by Elsevier B.V. All 
rights reserved. 
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INTRODUCTION 
 
Iron is a component of several metalloproteins involved in crucial metabolic processes such as   
oxygen sensing and   transport, energy metabolism and DNA synthesis. However, iron in excess is 
detrimental, as it can catalyze the formation of damaging radical species via Fenton-type reactions 
[1].  In normal conditions, iron  toxicity is prevented by the  binding of extracellular iron  in the  
plasma to  transferrin and  by  storage of intracellular iron  in a  protein with high   storage  capacity, 
ferritin  [2].  In addition, plasma iron levels are tightly regulated by the action of the peptide 
hormone hepcidin. Hepcidin, which is mostly secreted in the liver,  promotes the  degradation of 
the  iron  exporter ferroportin expressed on  the  surface of  iron-releasing cells,  thus reducing 
intestinal  iron   absorption  and   its   mobilization  from   hepatic stores, and  promoting iron  
retention within erythrophagocyto- sing   macrophages  [2].   Nevertheless, mutations  in   the   
genes encoding hepcidin (Hamp)  or  other key  regulatory proteins like HFE, hemojuvelin or 
transferrin receptor 2 result in inappropriately low  hepcidin levels  and  lead  to the  development 
of Hereditary Hemochromatosis (HH),  an  autosomal recessive disorder that is characterized by 
excessive absorption of dietary iron  and its deposition in the  parenchymal cells of the  liver and 
other body organs [3]. The liver, in particular, has the capacity to accumulate a great amount of iron 
and is thus particularly exposed to its toxic effects [4]. Cellular injury is presumably caused by 
oxygen radical-mediated damage to cellular organelles, leading to hepatocyte death. The HH 
disease penetrance is variable though. Whilst the chronic accumulation of iron  in the  organism 
per se is reasonably well  tolerated in  most individuals,  some HH  patients  develop liver  fibrosis 
and  cirrhosis, and  in some cases  primary hepatocellular     carcinoma   [3].    In    rodent   models,   
long-term   iron supplementation per se fails to induce significant liver damage [5, 6], suggesting 
that under normal conditions organisms activate mechanisms that allow an   adaptation to 
increased oxidative insult. 
Transcription factor Nuclear factor-erythroid 2-related factor 2 (Nfe2l2/Nrf2) is a bZIP redox-
sensitive transcription factor that regulates the transcriptional induction of a battery of antioxidant 
response element (ARE)-containing genes in response to cellular stresses. There  is  growing 
evidence that NRF2 is  an  important modifier of diseases involving oxidative stress (e.g. 
inflammatory and  neurodegenerative diseases, and  cancer) [7] and  the  liver  of Nrf2-/- mice  is 
reportedly more susceptible to oxidative and electrophilic stress [8]. However, the protective role 
of NRF2 in iron overload disease remains undetermined.  Here, we investigated whether NRF2 is 
critical for the protection of liver parenchymal cells against iron toxicity in vitro and in vivo. 
 
MATERIALS AND METHODS 
 
Animals and experimental design 
 
C57BL/6J mice and Nrf2-/- mice on a C57BL/6J background [9] (Riken, Japan) were housed and 
bred at the ‘Instituto de Biologia Molecular e Celular’ animal facility. Male mice (16 week-old) were 
fed standard rodent chow (Global rodent diet, Harlan Laboratories, Barcelona, Spain) or iron-rich 
diet (Global rodent diet supplemented with 2.0% carbonyl iron) for 2 weeks. In a subsequent 
experiment, Nrf2-/- animals were maintained on the iron-rich diet for the same time period and 
injected daily with either (2-(2,2,6,6-tetramethylpiperidin-1-oxyl-4-ylami- no)-2-xoethyl) 
triphenylphosphonium    chloride   monohydrate   (mito-TEMPOL, Santa Cruz  Biotechnology, 
Heidelberg, Germany) (10  mg/kg intraperitoneally) or saline (control), starting from the day 
before the start of dietary supplementation. At the end of the dietary treatment, mice were 
anaesthetized, blood was collected by retro-orbital bleeding, and the animals were sacrificed for 
organ collection. 
Since the saline injections in Nrf2-/- animals on iron-rich diet had no effect on any of the parameters 
assessed when comparing with Nrf2-/- animals on the same diet, samples from both groups were 
pooled for statistical analysis. 
 
Cell cultures 
 
Primary hepatocyte cultures from C57BL/6 (Nrf2+/+) and Nrf2-/- mice were prepared as described 
in Supplementary data. 
For a full description of Materials and methods, see Supplementary data. 
 
Version: Postprint (identical content as published paper) This is a self-archived document from i3S – Instituto de 
Investigação e Inovação em Saúde in the University of Porto Open Repository For Open Access to more of our 
publications, please visit http://repositorio-aberto.up.pt/  
 
A
0
1
/0
0
 
 
RESULTS 
 
NRF2 activation protects mouse hepatocytes from iron toxicity 
 
Under oxidative stress, NRF2 escapes proteasomal degradation and  is translocated to  the  nucleus, 
where it  activates the  tran- scription of  a  battery of  ARE-containing  cytoprotective  genes [7].  
The activation of NRF2 by  iron  was  investigated in primary hepatocyte cultures derived from   
wild-type and   Nrf2-/- mice that were incubated with ferric ammonium citrate (FAC), a source of 
inorganic iron  that is rapidly taken up  by  cultured cells  and mimics the  non-transferrin-bound 
iron  found in  the  plasma  of hemochromatosis patients  [10,11]. By immunofluorescence, we show 
an increase of NRF2 in the nuclei of wild-type hepatocytes at the end of 17 h of incubation with FAC 
(1.71 µg/ml) (Fig. 1A). 
We also monitored the mRNA expression of three prototypical NRF2 target genes in hepatocytes 
exposed to FAC. In basal conditions, wild-type hepatocytes expressed higher levels   of Nqo1, Gclc, 
and Gsta1 than Nrf2 -/- cells.  Incubation with FAC for 24 h significantly increased the steady-state 
levels of these genes in wild-type hepatocytes but   not   in Nrf2-/- cells, showing that NRF2 is 
required for their transcriptional activation by   iron (Fig. 1B). 
After demonstrating that NRF2 is activated by iron in wild- type hepatocytes, we assessed whether 
Nrf2-/- hepatocytes were more susceptible to iron   toxicity.  Cells were incubated with increasing 
concentrations of FAC or ammonium citrate (AC) as control for 24 h and their viability was assessed 
by the MTT assay, which measures the formation of a water-insoluble MTT formazan by 
mitochondrial dehydrogenases of living cells. As depicted in Fig. 1C, AC had no effect on the activity 
of hepatocytic mitochondrial dehydrogenases in either wild type or Nrf2-/- cells. While wild-type 
hepatocytes were resistant to all concentrations of FAC, a dramatic, dose-dependent reduction in 
the activity of mitochondrial dehydrogenases was observed in Nrf2-/- hepatocytes.  In the latter, 
FAC treatment caused morphological alterations that included rounding up of hepatocytes 
(Supplementary Fig. 1). We then performed a propidium iodide (PI) uptake assay that measures 
the   loss of cytoplasmic membrane integrity in dead cells.  Incubation with FAC (1.714 µg/ml) 
caused a significant increase in the number of PI-positive nuclei in Nrf2-/- hepatocytes but   not   
their wild-type counterparts (Fig.  1D). We inspected the   nuclear morphology of PI-positive cells 
for the presence of apoptotic bodies. As a positive control, we incubated Nrf2-/- cells with a 
concentration of staurosporine that induces apoptosis in mouse primary hepatocytes [12].   
Staurosporine- treated cells displayed chromatin margination and condensation, two   typical 
features of apoptotic cells.  In Nrf2-/- hepatocytes incubated with FAC, however, we did not observe 
any nuclei with the typical features of apoptosis (Fig. 1E), which suggests that iron kills Nrf2-/-   
hepatocytes by primary necrosis rather than apoptosis. 
Finally, we investigated the  formation of 8-hydroxy-2’-deoxy- guanosine  (8-OHdG),   a  product of  
oxidatively damaged  DNA formed by  hydroxyl radical or  singlet  oxygen [13],  in  mouse 
hepatocytes incubated with iron.   DNA damage was   measured using the   alkaline comet assay as 
human 8-hydroxyguanine DNA glycosylase 1 (hOGG1)-sensitive sites.  hOGG1 is considered to 
detect 8-OHdG  in cell culture experiments with great specificity [14]. Fig. 1F shows the level of 
hOGG1 sensitive sites in hepatocyte cultures after 24 h   exposure to   FAC.  Notably,   iron increased 
hOGG1-sensitive sites exclusively in Nrf2-/- hepatocytes,   which suggests that the   latter are   more 
susceptible to iron-induced oxidative stress. 
 
NRF2 protects mice against dietary iron-induced liver injury 
 
C57BL/6 (wild-type) and Nrf2-/- mice were either fed standard rodent chow or a diet containing 
2.0% carbonyl iron (iron-rich diet) ad libitum for 2 weeks. No significant differences in the relative 
liver weight were found. The levels of non-heme liver iron in animals of both strains under standard 
diet were not significantly different either. Feeding carbonyl iron increased the hepatic iron stores, 
transferrin saturation and serum iron levels significantly, irrespective of the Nrf2 status (Table 1). 
Significant increases in hepatic total ferritin levels   (Fig.  2A)  and   in the steady-state mRNA   levels    
of   Hamp   and    Hamp2   were also observed in both wild-type and Nrf2-/- mice fed iron-rich diet 
(Fig. 2B). We  conclude that the  lack  of Nrf2 had  no  impact on the  hepatic iron  loading or on  the  
ability of the  liver  to respond by activating key regulators of iron  homeostasis. 
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We then determined whether the hepatic iron loading altered the expression of Nrf2 or of its target 
genes. As expected, wild- type mice   expressed significantly higher levels   of Nrf2, Nqo1, and   Gsta1 
mRNA at steady-state in the   liver (Fig.  2C).  Whilst the  steady-state mRNA levels  of Nrf2 were 
not  altered by dietary iron,  the  iron-rich diet  caused a  significant increase in  hepatic Nqo1 and 
Gsta1 mRNA levels  in wild-type but  not in Nrf2-/- mice, demonstrating that these genes are  
regulated by dietary iron  in an  NRF2-dependent manner (Fig. 2C). NQO1 protein levels also 
increased in the livers of wild-type but not Nrf2-/- mice under iron-rich diet (Fig. 2D). 
The  next step was  to  determine if the  lack  of  NRF2 would affect  the  capacity of mice  to handle 
the  iron overload in comparison  with wild-type animals. Whilst we  found no  major alterations  
in  the   spleen, heart,  pancreas  or  duodenum (data not shown), the  analysis of  liver  histology 
revealed striking differences between  wild-type and   Nrf2-/- mice   in  what  concerns the   
preservation of  liver   architecture and   the   pattern of  iron deposition (Fig. 3A). As expected, 
none of the animals on normal diet displayed positive Perls’ Prussian blue staining for hepatic iron.   
In   wild-type  mice    fed   iron-rich  diet,    iron   deposition occurred predominantly in the  
hepatocytes adjacent to the  portal tracts and  in some animals also  in midzone hepatocytes 
(sidero- sis grades 1–2),  sparing the  Kupffer  cells,  which mimics the  typical  pattern of iron  
deposition found in  HH patients. In Nrf2-/- mice,   hepatocellular  siderosis  extended  from   the   
periportal regions  to   reach  midzone  or   centrilobular  regions  (siderosis grades 1–3),  and  was  
often less  granular (Fig. 3A). 
Liver  sections stained  with  haematoxylin and eosin (H&E) revealed the   existence of  confluent 
areas of  necrosis in  most Nrf2-/-   mice   fed  iron-rich diet,   ranging from   focal  confluent necrosis 
(necrosis grade 1) to  panacinar or  multiacinar necrosis (grade 6)  (Fig. 3A). Hepatocytic necrosis 
was evidenced by the acidophilic degeneration of hepatocytes with nuclei in advanced stage of 
karyolysis or karyorrhexis, and by the presence of hepatocytes with swollen cytoplasm (ballooning 
degeneration of the hepatocytes) (Fig. 3A and Supplementary Fig. 2). Apoptotic cells were 
occasionally found in periportal areas, but their number was greatly outnumbered by those 
presenting the typical features of oncotic necrosis. Hemorrhage was observed in the individuals 
with the highest necrosis scores (Supplementary Fig. 2). 
Necrotic and apoptotic cell death result in distinct ultrastructural changes to hepatocellular 
membranes and organelles. Electron microscopy showed that periportal hepatocytes of wild-type 
and  Nrf2-/- mice  fed  normal diet  presented abundant glycogen and  rough endoplasmic reticulum 
(RER), and  regularly shaped mitochondria with intact cristae (Fig. 3B). In hepatocytes from wild-
type mice fed iron-rich diet we found an abundance of secondary lysosomes, most of which 
containing electron-dense (presumably iron-rich) material. No major changes were observed 
regarding the morphology of mitochondria or the RER (Fig. 3B). Hepatocytes of Nrf2-/- animals fed  
iron-rich diet  also  displayed evidence of lysosomal activation but  the  most prominent feature 
was  the  diffuse cellular edema (oncosis) affecting the  totality of hepatocytes. There was gross 
damage to the mitochondria, which appeared swollen, with the cristae in various stages of 
disintegration.   In some hepatocytes, we observed swelling of the   inner membrane-matrix 
compartment, whereas in others there was rupture of the outer mitochondrial membrane.  
Proliferation of smooth endoplasmic reticulum (SER) and dilated RER with loss of ribosomes were 
observed (Fig. 3B and C). We found evidence of autolytic cell destruction in disintegrating 
(necrotic) hepatocytes, including the loss of cytoplasmic and organelle membrane integrity, and 
the presence of amorphous cytoplasm (Fig.  3C). Hepatocytic necrosis often results in acute 
inflammatory reaction [15]  and  accordingly hepatocytic cell death was  associated with dense 
inflammatory infiltrates streaming out  from  the  portal tri- ads  (Fig. 3A and  Supplementary Fig. 
2), which included macro- phages, lymphocytes and  polymorphonuclear cells  (Fig. 3C, left panel).  
Lobular   inflammation was   confirmed by a significant increase in the number of CD45+ leukocytes 
(Fig. 4A). The association of these acute inflammatory infiltrates with hepatocytic necrosis was 
illustrated by the extensive TUNEL staining of contiguous hepatocytes, indicative of DNA 
fragmentation (Fig. 4B). We observed both nuclear and cytoplasmic staining of swollen cells, as 
typically seen in cells undergoing oncotic necrosis due to the release of nucleases from infiltrating 
inflammatory cells [16–18]. We also evaluated the levels of cleaved caspase 3, a critical executioner 
of apoptosis [19].  As depicted in Supplementary further supports the predominance of necrotic 
rather than apoptotic cell death. Accordingly, we  found a  significant rise  in  the activity of  the   
serum transaminases alanine aminotransferase (ALT) and  aspartate aminotransferase (AST), 
which are  released by   injured  hepatocytes,  in   Nrf2-/- mice    fed   iron-rich  diet (Fig. 4D). Finally, 
we found a significant elevation in the number of 8-OHdG  immunoreactive  nuclei in  perivascular 
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hepatocytes from   Nrf2-/- mice   fed  iron-rich diet   (Fig.  4C), indicating that the livers of these 
animals were under oxidative stress. 
The  mitochondria are  the  major site  of intracellular reactive oxygen species (ROS) production 
and  excessive iron  may  lead to mitochondrial dysfunction [20], which could  result in the  leak- 
age  of mitochondrial ROS into  the  cytosol. The mitochondria of hepatocytes from Nrf2-/- mice fed 
iron-rich diet were swollen (Fig. 3B and C), which is known to cause the onset of mitochondrial 
permeability transition (MPT). MPT, in turn, is a cause of both apoptotic and necrotic hepatocytic 
cell death, via the release of pro-apoptotic factors and a reduction in cellular ATP, respectively 
[17,21]. To determine if the  mitochondria played a significant  role in the  increased susceptibility 
of Nrf2-/- hepatocytes to dietary iron  overload, a group of Nrf2-/- mice  on  iron-rich diet received 
daily injections of mito-TEMPOL (10 mg/kg), a derivative of the  antioxidant TEMPOL that is 
targeted to  the  mitochondria [22,23]. The antioxidant therapy did not  affect  the  uptake of iron 
from  the  diet  or  its  deposition in  the  liver,  as  the  animals displayed similar grading of hepatic 
siderosis (Fig. 3A) and  similar levels  of hepatic non-heme iron,  serum iron  and  transferrin satu- 
ration to  those of  Nrf2-/- mice  on  the  same diet  that did  not receive mito-TEMPOL  (Table   1).  
However, the   necrosis scores were similar to those of Nrf2-/- mice on normal diet (Fig. 3A). 
Histological (Fig.   3A)   and    ultrastructural (Fig.   3B)   analysis showed that the   antioxidant 
therapy prevented hepatocytic necrosis.   We    found  no    evidence   of   lobular  inflammation (Fig. 
4A), hepatocytic DNA fragmentation (Fig. 4B) or  oxidation (Fig. 4C) in these animals, and  the  levels  
of serum ALT and  AST were not  significantly different from  those of animals on normal diet  (Fig. 
4D). In summary, we demonstrate that the hepatotoxicity of dietary iron towards Nrf2-/- animals is 
abrogated via the use of an antioxidant targeted to the mitochondria. 
 
DISCUSSION 
 
In HH patients, a genetic predisposition towards excessive absorption of dietary iron causes iron 
accumulation in tissues. In some individuals, hepatic iron overload results in liver injury, presum- 
ably as a result of the contribution of environmental or genetic risk factors. Alcohol consumption 
is a well-recognized environmental risk factor [3], but genetic factors remain poorly understood. 
So far the search for genetic modifiers has focused on the identification of modifiers of iron loading 
rather than of genetic determinants of protection against excessive iron. 
Transcription factor NRF2 coordinates the adaptation of cells and organisms to oxidative stress [7]. 
Previous work showed that Nrf2-/- mice   are   more susceptible to   ferric   nitrilotriacetate- induced 
renal toxicity [24]. Here, we focused on the hepatotoxiccytochrome P450–dependent metabolism 
[26]. We have also investigated the ability of hepatocytes and liver from Nrf2-null mice to tolerate 
iron excess. We show for the first time that the activation of NRF2 signaling by iron is associated 
with protection against hepatocytic cell death in vitro and in vivo. The  fact  that Nrf2-/- mice   fed   
iron-rich  diet   develop  marked  liver   injury despite a similar hepatic iron  loading to  wild-type 
animals is of great relevance because although the  liver is particularly exposed to the  toxic  effects 
of iron  in excess, rodents are  generally resistant to  iron-induced liver  injury. Mouse models of 
HH develop the spontaneous iron overload phenotype seen in human patients without developing 
significant iron-induced liver injury [27,28]. Likewise, the supplementation of mouse diets with 
carbonyl iron is generally well tolerated, despite the   substantial increase in hepatic iron [5,29].  In 
our view, this is because wild-type hepatocytes are equipped with efficient antioxidant defenses 
that make them resistant to iron-induced ROS. Swelling of hepatocytes, causing ALT/AST release, 
as observed in Nrf2-/- mice fed iron-rich diet, are typical features of ROS-induced necrosis in vivo 
[18]. Further evidence of iron-mediated oxidative stress is provided by the increased levels of a 
specific marker of oxidative DNA damage (8- OHdG) in hepatocytes from Nrf2-/- mice fed iron-rich 
diet  and the  abrogation of the  hepatotoxicity of dietary iron  via  the  use of an antioxidant that is 
targeted to the mitochondria (mito-TEMPOL), which is capable of trapping free radicals and  
inhibiting the catalytic action of Fe2+ [30]. 
A striking feature of necrotic hepatocytes from Nrf2-/- mice fed iron-rich diet was the extreme 
swelling of mitochondria. In hepatocytes, non-heme iron that is initially sequestered in lysosomes 
may be released and taken up into mitochondria, where it catalyzes toxic ROS-mediated reactions 
[31]. This may open nonspecific permeability transition pores in the mitochondrial inner 
membrane that cause mitochondrial membrane depolarization, uncoupling of oxidative 
phosphorylation, and large scale mitochondrial swelling, leading to hepatocyte necrosis from 
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adenosine triphosphate depletion. Notably, an extreme swelling of mitochondria is also found in 
severe HH patients [32]. 
Hepatocytic cell death in Nrf2-/- mice fed iron-rich diet was also favored by the development of 
severe portal inflammation. Oncotic necrosis of hepatocytes causes cytoplasmic swelling and 
progressive disintegration of cytoplasmic membranes. The release of material from necrotizing 
cells into the extracellular compartment often results in an inflammatory reaction [15].  
In conclusion, we describe the Nrf2-/- mouse fed iron-rich diet as a valid model for the study of 
dietary iron-mediated liver injury and identify NRF2 as a potential modifier of liver disease in iron 
overload pathology. We anticipate that resistance to oxidative stress may be a modifier of disease 
progression in HH and other iron overload diseases. Functional polymorphisms in Nrf2 have been 
described, which may lead to loss of function. Based on our current results, it is tempting to 
speculate that individuals with a genetic predisposition to develop iron overload (such as HH 
patients) who also carry the Nrf2 single nucleotide polymorphisms would be at higher risk of 
developing iron overload-related pathology. This possibility should warrant great attention in the 
future.  
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Fig. 1.  NRF2 is activated by iron and protects mouse primary hepatocytes from iron toxicity. Unless 
stated otherwise, hepatocytes were incubated with 1.71 µg/ml FAC or AC for 24 h.  (A)  
Immunofluorescence detection of NRF2 at 17 h of incubation. The increased fluorescence in nuclei 
of wild-type hepatocytes treated with FAC is representative of 3 independent experiments. (B) The 
mRNA levels of cytoprotective genes were assessed by real-time RT-PCR. (C) Hepatocyte viability 
was measured with the MTT assay. *p <0.05 when compared with Nrf2-/- AC, #p <0.05 when 
compared with wild-type FAC. (D) Hepatocytes were stained with the DNA-binding fluorochrome 
propidium iodide, which is impermeable to the normal plasma membrane but stains nuclei of 
necrotic and late apoptotic cells. Nuclei were counterstained with DAPI. (E) Fluorescence 
micrographs showing representative nuclei of Nrf2-/- hepatocytes incubated with FAC or 
staurosporine [Staur.] (5 µM). Note the typical features of apoptosis in staurosporine-treated cells, 
including chromatin margination (arrows) and condensation (arrowheads). (F) Oxidatively 
modified DNA was measured using the alkaline comet assay as hOGG1-sensitive sites. (This figure 
appears in color on the web.) 
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Table 1. Iron loading parameters in mice fed normal or iron-rich diet. 
 
ap <0.001 vs. animals of the same genotype on normal diet. 
bp >0.05 vs. Nrf2-/- animals on iron-rich diet. 
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Fig. 2. Activation of key iron homeostasis genes and antioxidant/cytoprotective genes in the liver 
of mice fed iron-rich diet. Wild-type and Nrf2-/- mice were fed standard rodent chow or iron-rich 
diet for 2 weeks. (A) Western blot and densitometric quantification of total ferritin in liver extracts. 
(B) Transcriptional levels of the two genes encoding mouse hepcidin were determined by real-time 
RT-PCR. (C) The mRNA expression levels of Nrf2, Gsta1, and Nqo1 were assessed by real-time RT-
PCR. (D) Western blot and densitometric quantification of NQO1 in liver extracts. 
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Fig. 4. Evidence of lobular inflammation, hepatotocytic cell death and oxidative DNA damage in 
Nrf2-/- mice fed iron-rich diet. Wild-type and Nrf2-/- mice were fed standard rodent chow or iron-
rich diet for 2 weeks. A group of Nrf2-/- animals on iron-rich diet received daily injections of the 
antioxidant mito-TEMPOL. Representative images and quantification of CD45+ leukocytes (A), 
TUNEL-positive hepatocytes (B), and hepatocytic nuclei immunoreactive for 8-hydroxy-20-
deoxyguanosine (8-OHdG) (C) in liver tissues are depicted. (D) ALT and AST activities were 
measured in mouse serum. n.s., not significant. (This figure appears in color on the web.) 
 
 
 
Fig. 3. Histopathological and ultrastructural features in the liver of Nrf2-/- animals fed iron-rich diet. 
Wild-type and Nrf2-/- mice were fed standard rodent chow or iron-rich diet for 2 weeks. A group of 
Nrf2-/- animals on iron-rich diet received daily injections of the antioxidant mito-TEMPOL. (A) 
Representative liver sections and grading of hepatic siderosis and necrosis. Note the swollen and 
eosinophilic hepatocytes, and confluent areas of necrosis in Nrf2-/- mice fed iron-rich diet, whereas 
in all other experimental groups the liver was histologically normal with no change in the lobular 
architecture. (B) TEM analysis of periportal hepatocytes denoting abundant glycogen (G), rough 
endoplasmic reticulum (RER) and mitochondria (M) in animals fed normal diet and the 
accumulation of electron-dense material within phagolysosomes (PL) in animals fed iron-rich diet. 
Hepatocytes from Nrf2-/- mice fed iron-rich diet showed gross mitochondrial swelling with 
decreased matrix density and outer membrane rupture, and hypertrophied smooth endoplasmic 
reticulum (SER). Note the normal mitochondrial morphology in the Nrf2-/- animals fed iron-rich 
diet that received mito-TEMPOL. (C) Ultrastructural features of hepatocytic cell death in Nrf2-/- 
animals fed iron-rich diet are depicted, including disintegrating (necrotic) hepatocytes containing 
membranous phagolysosomes and displaying plasma membrane disruption (small arrow), a giant 
secondary lysosome containing electron-dense material and lipofuscin (long arrow), and an 
‘acidophilic’ body formed from a dying hepatocyte where fat droplets, disintegrated nucleus, 
mitochondria and phagolysosomes are still recognizable (small arrowhead). Lipid deposition (L) 
and infiltration of red blood cells (RBC) and inflammatory cells were observed in association with 
hepatocytic cell death (left panel). Vesicular SER and irregularly shaped mitochondria (M) with 
cristolysis, swelling and outer membrane rupture are depicted. (This figure appears in color on the 
web.) 
